Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Beam Therapeutics
(BEAM)
NASDAQ
:BEAM
BEAM
Beam Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Beam Therapeutics (BEAM) Stock News & Sentiment
Compare
Follow
2,123
Followers
Premium
Ratings
Beam Therapeutics: De-Risked Late-Stage Pipeline, Clear FDA Pathways, and Strong Cash Runway Underscore Buy Rating and $80 Target
21h ago
BEAM
Premium
Company Announcements
Beam Therapeutics outlines 2026 strategy and extends runway
3d ago
8K
BEAM
Premium
Market News
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
14d ago
BEAM
Premium
Market News
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
15d ago
BEAM
IONS
Premium
Company Announcements
Beam Therapeutics Gains $255M from Orbital Acquisition
1M ago
8K
BEAM
Premium
Ratings
Beam Therapeutics’ Promising BEACON Trial and Advanced Manufacturing Boost Buy Rating
1M ago
BEAM
Premium
Ratings
Promising Clinical Data and Market Potential Drive Buy Rating for Beam Therapeutics’ Sickle Cell Treatment
1M ago
BEAM
More BEAM News >
BEAM News on the Web
All News
Bearish News
Bullish News
2026-01-13
BEAM Outlines Key Strategic & Pipeline Goals for 2026, Stock Rises
Zacks
Bullish
2026-01-12
Stocks making the biggest moves midday: Citigroup, Abercrombie, Vistra, Duolingo and more
CNBC
Neutral
2026-01-12
Beam FDA alignment could accelerate review, says William Blair
The Fly
Neutral
2026-01-12
Beam Therapeutics Extends Cash Runway to 2029 as FDA Clears Accelerated Path for Lead Gene-Editing Therapies
Market Chameleon
Neutral
2026-01-12
Beam Therapeutics To Report BEAM-302 Trial Data In Q1; Submit Risto-cel BLA By Year-End 2026
rttnews
Neutral
2026-01-12
BEAM Secures FDA Support and Extends Cash Runway to 2029: Key Milestones Elevate Genetic Medicine Ambitions
Market Chameleon
Neutral
2026-01-06
Three Genomics Stocks Worth Tracking This Year
Zacks
Neutral
2026-01-01
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
TipRanks News
Neutral
145
Results | Showing
1
out of
19
News Score - Last 7 Days
Neutral
BEAM
Sector Average
Media Buzz
This Week
6 articles
Weekly Average
2.75 articles
News Sentiment
This Week
100%
Sector Average
58%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is BEAM’s Media Buzz Sentiment?
6 articles about BEAM were published this week. In an average week, 2.75 articles are published.
What is BEAM’s weekly average amount of articles?
In an average week, 2.75 articles about BEAM are published.
What is BEAM’s News Sentiment?
100% of articles about BEAM were positive this week, compared to its sector average of 58%.
Healthcare Stocks that are Trending in the News
KRYS
Krystal Biotech
WST
West Pharmaceutical Services
SEMHF
Siemens Healthineers AG
RPRX
Royalty Pharma
NYXH
Nyxoah
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.